We are live on
!
Find out more
SCM
Silvant Capital Management Portfolio holdings
AUM
$2.89B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.35%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$585M
AUM Growth
+$25.3M
(+4.5%)
Cap. Flow
-$29M
Cap. Flow
% of AUM
-4.96%
Top 10 Holdings %
Top 10 Hldgs %
46.14%
Holding
338
New
9
Increased
8
Reduced
156
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$3.6M |
| 2 |
NVIDIA
NVDA
|
+$1.81M |
| 3 |
Natera
NTRA
|
+$1.51M |
| 4 |
Pfizer
PFE
|
+$1.41M |
| 5 |
SentinelOne
S
|
+$706K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.86M |
| 2 |
Microsoft
MSFT
|
+$2.82M |
| 3 |
Mastercard
MA
|
+$2.78M |
| 4 |
Comcast
CMCSA
|
+$2.56M |
| 5 |
Apple
AAPL
|
+$2.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35% |
| 2 | Healthcare | 14.27% |
| 3 | Consumer Discretionary | 13.55% |
| 4 | Communication Services | 11.79% |
| 5 | Financials | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
DraftKings
DKNG
$11.6B
| $1.57M | 0.27% |
57,353
-2,185
| -4% | -$85.6K |
|
77
Insulet
PODD
$11.5B
| $1.57M | 0.27% |
5,913
-299
| -5% | -$86.7K |
|
78
Emerson Electric
EMR
$83.9B
| $1.55M | 0.26% |
16,674
-679
| -4% | -$63.9K |
|
79
Vulcan Materials
VMC
$34.8B
| $1.46M | 0.25% |
7,050
-330
| -4% | -$63.9K |
|
|
AVLR
80
DELISTED
Avalara, Inc.
AVLR
| $1.46M | 0.25% |
11,270
-494
| -4% | -$77.1K |
|
81
Restaurant Brands International
QSR
$25.7B
| $1.4M | 0.24% |
22,837
-1,227
| -5% | -$72.3K |
|
82
Air Products & Chemicals
APD
$65.7B
| $1.38M | 0.24% |
4,506
-183
| -4% | -$53.7K |
|
83
Colgate-Palmolive
CL
$73.1B
| $1.32M | 0.23% |
15,432
-651
| -4% | -$50.8K |
|
|
EXAS
84
DELISTED
Exact Sciences
EXAS
| $1.27M | 0.22% |
16,287
-765
| -4% | -$67.5K |
|
85
Universal Display
OLED
$3.68B
| $1.23M | 0.21% |
7,443
-328
| -4% | -$54.1K |
|
86
Fair Isaac
FICO
$24.3B
| $1.18M | 0.2% |
2,718
-120
| -4% | -$47.6K |
|
87
Tyler Technologies
TYL
$12.7B
| $1.17M | 0.2% |
2,177
-169
| -7% | -$87.5K |
|
88
Teledyne Technologies
TDY
$30.4B
| $1.1M | 0.19% |
2,525
-162
| -6% | -$70.5K |
|
|
SI
89
DELISTED
Silvergate Capital Corporation
SI
| $1.09M | 0.19% |
7,388
-241
| -3% | -$41.2K |
|
90
Chubb
CB
$135B
| $1.09M | 0.19% |
5,628
| – | – |
|
91
Union Pacific
UNP
$174B
| $1.08M | 0.19% |
4,300
+2,643
| +160% | +$626K |
|
92
Abbott
ABT
$183B
| $1.05M | 0.18% |
7,453
| – | – |
|
93
Coinbase
COIN
$38.6B
| $1.05M | 0.18% |
4,156
-157
| -4% | -$45.6K |
|
94
Q2 Holdings
QTWO
$3.8B
| $1.01M | 0.17% |
12,752
-820
| -6% | -$66.2K |
|
|
PXD
95
DELISTED
Pioneer Natural Resource Co.
PXD
| $1M | 0.17% |
5,491
-327
| -6% | -$60.2K |
|
96
Saia
SAIA
$9.27B
| $907K | 0.16% |
2,690
-682
| -20% | -$212K |
|
97
Tandem Diabetes Care
TNDM
$1.34B
| $905K | 0.15% |
6,011
-1,296
| -18% | -$175K |
|
98
Teladoc Health
TDOC
$1.22B
| $903K | 0.15% |
9,834
-434
| -4% | -$51.9K |
|
99
Snap
SNAP
$7.89B
| $898K | 0.15% |
19,088
-839
| -4% | -$47.2K |
|
100
IBM
IBM
$211B
| $887K | 0.15% |
6,640
-305
| -4% | -$38.3K |
|
Similar funds
AG
NRCM
BAM
PFM
DMIC
LIP
CCM
HCC
Silvant Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Silvant Capital Management held 338 positions worth $585M, up 4.5% from $560M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Silvant Capital Management withdrew a net $29M in Q4 2021, closing 5 positions and reducing 156 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $350K position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Silvant Capital Management opened a new position in Netflix worth $3.4M.
- Silvant Capital Management's largest Q4 2021 buy was Netflix: 56,410 shares worth $3.4M.
- Silvant Capital Management added most to NVIDIA in Q4 2021, an estimated $1.81M increase.
- Silvant Capital Management's biggest Q4 2021 reduction was Visa, cutting an estimated $4.86M.
- Silvant Capital Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2021, selling an estimated $350K.
- Silvant Capital Management's ten largest holdings make up 46% of its $585M portfolio in Q4 2021.
- Silvant Capital Management opened 9 new positions and closed 5 in Q4 2021.
- Silvant Capital Management's portfolio value rose 4.5% quarter-over-quarter to $585M.
Based on Silvant Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.